🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Otherwise healthy women who develop preeclampsia during pregnancy are more ...
Status
Completed
Location
University of Iowa
Start Date
2023-12-08
Trial ID
NCT06157580
Treatments Being Tested
This phase II clinical trial design with a safety run-in period will be use...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-10-01
Trial ID
NCT05408026
Treatments Being Tested
Study combination use of cisplatin plus romidepsin and nivolumab in metasta...
Status
Active Not Recruiting
Location
University of Kansas Cancer Center - Clinical Research Center
Start Date
2015-07-17
Trial ID
NCT02393794
Treatments Being Tested
Children with neurofibromatosis type 1 (NF1) commonly suffer from the effec...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2021-02-23
Trial ID
NCT04481048
Treatments Being Tested
This phase II trial studies the side effects and how well combination chemo...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2007-07-11
Trial ID
NCT00501826
This is a first-in-human, multi-center, open-label clinical study with sepa...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2016-01
Trial ID
NCT02649790
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Sylvester Comprehensive Cancer Center - University of Miami
Start Date
2006-05
Trial ID
NCT00165802
Treatments Being Tested
Endometrial cancer (EC) is the fourth most common cancer in United States w...
Status
Recruiting
Location
Lineberger Comprehensive Cancer Center
Start Date
2023-10-23
Trial ID
NCT05542407
Treatments Being Tested
This trial is a single-centre, randomized, double-blind, placebo-controlled...
Status
Completed
Location
Skånes universitetssjukhus
Start Date
2023-03-31
Trial ID
NCT05831644
Treatments Being Tested
This phase II trial studies how well Akt/ERK inhibitor ONC201 (ONC201) with...
Status
Terminated
Location
University of Wisconsin Carbone Cancer Center
Start Date
2018-11-13
Trial ID
NCT03733119
Treatments Being Tested